The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Chronic Obstructive Pulmonary Disease Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Chronic Obstructive Pulmonary Disease Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Chronic Obstructive Pulmonary Disease Treatment Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Chronic Obstructive Pulmonary Disease Treatment Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Chronic Obstructive Pulmonary Disease Treatment Drug include GSK, Novartis, Merck, Abbott, Boehringer Ingelheim, AstraZeneca, Roche, Teva and Vectura, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Chronic Obstructive Pulmonary Disease Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Obstructive Pulmonary Disease Treatment Drug.
The Chronic Obstructive Pulmonary Disease Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Chronic Obstructive Pulmonary Disease Treatment Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Obstructive Pulmonary Disease Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- GSK
- Novartis
- Merck
- Abbott
- Boehringer Ingelheim
- AstraZeneca
- Roche
- Teva
- Vectura
- Pfizer
- Mylan
- Allergan
- Cipla
- Akorn
Segment by Type
- Bronchodilators
- PDE-4 Inhibitors
- Steroids
- Others
Segment by Application
- Hospital
- Clinic
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disease Treatment Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bronchodilators
1.2.3 PDE-4 Inhibitors
1.2.4 Steroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Perspective (2018-2029)
2.2 Chronic Obstructive Pulmonary Disease Treatment Drug Growth Trends by Region
2.2.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Region (2018-2023)
2.2.3 Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Region (2024-2029)
2.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market Dynamics
2.3.1 Chronic Obstructive Pulmonary Disease Treatment Drug Industry Trends
2.3.2 Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disease Treatment Drug Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Revenue (2018-2023)
3.1.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Players (2018-2023)
3.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue
3.4 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in 2022
3.5 Chronic Obstructive Pulmonary Disease Treatment Drug Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disease Treatment Drug Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disease Treatment Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Obstructive Pulmonary Disease Treatment Drug Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Type (2018-2023)
4.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Type (2024-2029)
5 Chronic Obstructive Pulmonary Disease Treatment Drug Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disease Treatment Drug Historic Market Size by Application (2018-2023)
5.2 Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2018-2029)
6.2 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023)
6.4 North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2018-2029)
7.2 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023)
7.4 Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2018-2029)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2018-2029)
9.2 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023)
9.4 Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (2018-2029)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.2.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Abbott
11.4.1 Abbott Company Detail
11.4.2 Abbott Business Overview
11.4.3 Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.4.4 Abbott Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.4.5 Abbott Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.6.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.7.4 Roche Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.7.5 Roche Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.8.4 Teva Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.8.5 Teva Recent Development
11.9 Vectura
11.9.1 Vectura Company Detail
11.9.2 Vectura Business Overview
11.9.3 Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.9.4 Vectura Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.9.5 Vectura Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.10.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.10.5 Pfizer Recent Development
11.11 Mylan
11.11.1 Mylan Company Detail
11.11.2 Mylan Business Overview
11.11.3 Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.11.4 Mylan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.11.5 Mylan Recent Development
11.12 Allergan
11.12.1 Allergan Company Detail
11.12.2 Allergan Business Overview
11.12.3 Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.12.4 Allergan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.12.5 Allergan Recent Development
11.13 Cipla
11.13.1 Cipla Company Detail
11.13.2 Cipla Business Overview
11.13.3 Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.13.4 Cipla Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.13.5 Cipla Recent Development
11.14 Akorn
11.14.1 Akorn Company Detail
11.14.2 Akorn Business Overview
11.14.3 Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Introduction
11.14.4 Akorn Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
11.14.5 Akorn Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Bronchodilators
Table 3. Key Players of PDE-4 Inhibitors
Table 4. Key Players of Steroids
Table 5. Key Players of Others
Table 6. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2018-2023)
Table 10. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2024-2029)
Table 12. Chronic Obstructive Pulmonary Disease Treatment Drug Market Trends
Table 13. Chronic Obstructive Pulmonary Disease Treatment Drug Market Drivers
Table 14. Chronic Obstructive Pulmonary Disease Treatment Drug Market Challenges
Table 15. Chronic Obstructive Pulmonary Disease Treatment Drug Market Restraints
Table 16. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Players (2018-2023)
Table 18. Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug as of 2022)
Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Obstructive Pulmonary Disease Treatment Drug Product Solution and Service
Table 23. Date of Enter into Chronic Obstructive Pulmonary Disease Treatment Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Chronic Obstructive Pulmonary Disease Treatment Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Chronic Obstructive Pulmonary Disease Treatment Drug Revenue Market Share by Application (2024-2029)
Table 33. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size by Country (2024-2029) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 51. GSK Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 56. Novartis Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 61. Merck Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 62. Merck Recent Development
Table 63. Abbott Company Detail
Table 64. Abbott Business Overview
Table 65. Abbott Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 66. Abbott Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Boehringer Ingelheim Company Detail
Table 69. Boehringer Ingelheim Business Overview
Table 70. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 71. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 72. Boehringer Ingelheim Recent Development
Table 73. AstraZeneca Company Detail
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 76. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Roche Company Detail
Table 79. Roche Business Overview
Table 80. Roche Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 81. Roche Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Teva Company Detail
Table 84. Teva Business Overview
Table 85. Teva Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 86. Teva Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 87. Teva Recent Development
Table 88. Vectura Company Detail
Table 89. Vectura Business Overview
Table 90. Vectura Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 91. Vectura Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 92. Vectura Recent Development
Table 93. Pfizer Company Detail
Table 94. Pfizer Business Overview
Table 95. Pfizer Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 96. Pfizer Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Mylan Company Detail
Table 99. Mylan Business Overview
Table 100. Mylan Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 101. Mylan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 102. Mylan Recent Development
Table 103. Allergan Company Detail
Table 104. Allergan Business Overview
Table 105. Allergan Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 106. Allergan Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 107. Allergan Recent Development
Table 108. Cipla Company Detail
Table 109. Cipla Business Overview
Table 110. Cipla Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 111. Cipla Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 112. Cipla Recent Development
Table 113. Akorn Company Detail
Table 114. Akorn Business Overview
Table 115. Akorn Chronic Obstructive Pulmonary Disease Treatment Drug Product
Table 116. Akorn Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023) & (US$ Million)
Table 117. Akorn Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Type: 2022 VS 2029
Figure 3. Bronchodilators Features
Figure 4. PDE-4 Inhibitors Features
Figure 5. Steroids Features
Figure 6. Others Features
Figure 7. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Chronic Obstructive Pulmonary Disease Treatment Drug Report Years Considered
Figure 13. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Players in 2022
Figure 17. Global Top Chronic Obstructive Pulmonary Disease Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease Treatment Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Treatment Drug Revenue in 2022
Figure 19. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2018-2029)
Figure 21. United States Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2018-2029)
Figure 25. Germany Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Region (2018-2029)
Figure 33. China Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2018-2029)
Figure 41. Mexico Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Chronic Obstructive Pulmonary Disease Treatment Drug Market Share by Country (2018-2029)
Figure 45. Turkey Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Chronic Obstructive Pulmonary Disease Treatment Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 49. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 50. Abbott Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 51. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 52. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 54. Teva Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 55. Vectura Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 57. Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 58. Allergan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 59. Cipla Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 60. Akorn Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Treatment Drug Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
